Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
StAR-related lipid transfer domain containing 8 (STARD8) is a member of the Rho GTPase activating proteins family, with a characteristic lipid-binding START domain. It regulates GTPase activity (especially RHOA and CDC42), localizes to focal adhesions, regulates cell morphology, orchestrates membrane trafficking, and maintains organelle integrity. STARD8’s tumor suppressor function is indicated by inactivation mutations in multiple cancers. It plays developmental roles that are conserved across species, serving as a critical regulator of cellular architecture and signaling pathways implicated in cancer pathogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on StAR-related lipid transfer domain containing 8 (STARD8).